Structure-Based and Multiple Potential Three-Dimensional Quantitative Structure-Activity Relationship (SB-MP-3D-QSAR) for Inhibitor Design

The inhibitions of enzymes (proteins) are determined by the binding interactions between ligands and targeting proteins. However, traditional QSAR (quantitative structure-activity relationship) is a one-side technique, only considering the structures and physicochemical properties of inhibitors. In this study, the structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) is presented, in which the structural information of host protein is involved in the QSAR calculations. The SB-MP-3D-QSAR actually is a combinational method of docking approach and QSAR technique. Multiple docking calculations are performed first between the host protein and ligand molecules in a training set. In the targeting protein, the functional residues are selected, which make the major contribution to the binding free energy. The binding free energy between ligand and targeting protein is the summation of multiple potential energies, including van der Waals energy, electrostatic energy, hydrophobic energy, and hydrogen-bond energy, and may include nonthermodynamic factors. In the foundational QSAR equation, two sets of weighting coefficients {aj} and {bp} are assigned to the potential energy terms and to the functional residues, respectively. The two coefficient sets are solved by using iterative double least-squares (IDLS) technique in the training set. Then, the two sets of weighting coefficients are used to predict the bioactivities of inquired ligands. In an application example, the new developed method obtained much better results than that of docking calculations.

[1]  K. Goa,et al.  Zanamivir , 1999, Drugs.

[2]  T. Creamer,et al.  Solvation energies of amino acid side chains and backbone in a family of host-guest pentapeptides. , 1996, Biochemistry.

[3]  Stephen Hanessian,et al.  A method for induced-fit docking, scoring, and ranking of flexible ligands. Application to peptidic and pseudopeptidic beta-secretase (BACE 1) inhibitors. , 2006, Journal of medicinal chemistry.

[4]  W G Laver,et al.  A new series of C3-aza carbocyclic influenza neuraminidase inhibitors: synthesis and inhibitory activity. , 1998, Bioorganic & medicinal chemistry letters.

[5]  E Uriarte,et al.  Recent advances on the role of topological indices in drug discovery research. , 2001, Current medicinal chemistry.

[6]  M. Wang,et al.  Low-frequency Fourier spectrum for predicting membrane protein types. , 2005, Biochemical and biophysical research communications.

[7]  R K Robins,et al.  Analysis of the in vitro antitumor activity of novel purine-6-sulfenamide, -sulfinamide, and -sulfonamide nucleosides and certain related compounds using a computer-aided receptor modeling procedure. , 1991, Journal of medicinal chemistry.

[8]  Huanxiang Liu,et al.  In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase. , 2010, Molecular pharmaceutics.

[9]  K C Chou,et al.  An analysis of protein folding type prediction by seed-propagated sampling and jackknife test , 1995, Journal of protein chemistry.

[10]  R. D. Iii Cramer,et al.  Comparative Molecular Field Analysis (CoMFA). Part 1. Effect of Shape on Binding of Steroids to Carrier Proteins. , 1988 .

[11]  A. Benítez-Páez,et al.  Dissection of Functional Residues in Receptor Activity-Modifying Proteins Through Phylogenetic and Statistical Analyses , 2008, Evolutionary bioinformatics online.

[12]  W C Guida,et al.  The significance of chirality in drug design and development. , 2011, Current topics in medicinal chemistry.

[13]  W G Laver,et al.  Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. , 1997, Journal of the American Chemical Society.

[14]  E. Oldfield,et al.  Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates. , 2004, Journal of medicinal chemistry.

[15]  Qishi Du,et al.  Theoretical Derivation of Heuristic Molecular Lipophilicity Potential: A Quantum Chemical Description for Molecular Solvation , 2005, J. Chem. Inf. Model..

[16]  P. Cintas Tracing the origins and evolution of chirality and handedness in chemical language. , 2007, Angewandte Chemie.

[17]  Kuo-Chen Chou,et al.  Peptide reagent design based on physical and chemical properties of amino acid residues , 2007, J. Comput. Chem..

[18]  Yongbo Hu,et al.  Comparison of Several Molecular Docking Programs: Pose Prediction and Virtual Screening Accuracy , 2009, J. Chem. Inf. Model..

[19]  Ajay N. Jain,et al.  Parameter estimation for scoring protein-ligand interactions using negative training data. , 2006, Journal of medicinal chemistry.

[20]  Giuseppe Bifulco,et al.  Determination of the relative stereochemistry of flexible organic compounds by Ab initio methods: conformational analysis and Boltzmann-averaged GIAO 13C NMR chemical shifts. , 2002, Chemistry.

[21]  Brian J. Smith,et al.  Analysis of inhibitor binding in influenza virus neuraminidase , 2001, Protein science : a publication of the Protein Society.

[22]  Setsuzo Tejima,et al.  THE ROTATORY DISPERSION AND STEREOCHEMISTRY OF ORGANIC COMPOUNDS. VII. MONOSULFIDES AND DISULFIDES DERIVED FROM GLUCOSE AND GLUCOSAMINE. , 1965, Bulletin of the Chemical Society of Japan.

[23]  S. White,et al.  Membrane protein folding and stability: physical principles. , 1999, Annual review of biophysics and biomolecular structure.

[24]  René Thomsen,et al.  MolDock: a new technique for high-accuracy molecular docking. , 2006, Journal of medicinal chemistry.

[25]  J. Shim Understanding Functional Residues of the Cannabinoid CB1 Receptor for Drug Discovery , 2010 .

[26]  Xiaowu Chen,et al.  Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor. , 2000, Current medicinal chemistry.

[27]  G. Air,et al.  Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent. , 1999, Journal of medicinal chemistry.

[28]  Dapeng Li,et al.  Heuristic molecular lipophilicity potential (HMLP): Lipophilicity and hydrophilicity of amino acid side chains , 2006, J. Comput. Chem..

[29]  G. Klebe,et al.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.

[30]  Q Gu,et al.  Prediction of G-protein-coupled receptor classes in low homology using Chou's pseudo amino acid composition with approximate entropy and hydrophobicity patterns. , 2010, Protein and peptide letters.

[31]  E. Akı-Şener,et al.  3D-QSAR study on heterocyclic topoisomerase II inhibitors using CoMSIA , 2006, SAR and QSAR in environmental research.

[32]  Lukasz A. Kurgan,et al.  Prediction of protein folding rates from primary sequences using hybrid sequence representation , 2009, J. Comput. Chem..

[33]  Predrag Radivojac,et al.  Computational methods for identification of functional residues in protein structures. , 2011, Current protein & peptide science.

[34]  V. Papadopoulos,et al.  3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA. , 2006, Bioorganic & medicinal chemistry letters.

[35]  Kuo-Chen Chou,et al.  Multiple field three dimensional quantitative structure–activity relationship (MF‐3D‐QSAR) , 2008, J. Comput. Chem..

[36]  Qishi Du,et al.  Empirical formulation and parameterization of cation–π interactions for protein modeling , 2012, J. Comput. Chem..

[37]  Stephen H. White,et al.  Experimentally determined hydrophobicity scale for proteins at membrane interfaces , 1996, Nature Structural Biology.

[38]  Kuo-Chen Chou,et al.  Heuristic molecular lipophilicity potential (HMLP): A 2D‐QSAR study to LADH of molecular family pyrazole and derivatives , 2005, J. Comput. Chem..

[39]  K. Chou,et al.  Recent advances in QSAR and their applications in predicting the activities of chemical molecules, peptides and proteins for drug design. , 2008, Current protein & peptide science.

[40]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[41]  V. Gineitytė A simple topological factor determining the allowance of pericyclic reactions , 2008 .

[42]  Kuo-Chen Chou,et al.  Fragment‐based quantitative structure–activity relationship (FB‐QSAR) for fragment‐based drug design , 2009, J. Comput. Chem..

[43]  W G Laver,et al.  Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors. , 1998, Journal of medicinal chemistry.

[44]  A. Norman,et al.  Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody. , 2004, Journal of medicinal chemistry.

[45]  Xiaoqin Zou,et al.  Construction and Test of Ligand Decoy Sets Using MDock: Community Structure-Activity Resource Benchmarks for Binding Mode Prediction , 2011, J. Chem. Inf. Model..

[46]  E. Oldfield,et al.  Quantitative Structure-Activity Relationships for γδ T Cell Activation by Bisphosphonates , 2004 .

[47]  R. Stevens,et al.  Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Antiinfluenza Activity. , 1997 .

[48]  Q. Du,et al.  Energies and physicochemical properties of cation-π interactions in biological structures. , 2012, Journal of molecular graphics & modelling.

[49]  Robert D. Clark,et al.  SYBYL Line Notation (SLN): A Single Notation To Represent Chemical Structures, Queries, Reactions, and Virtual Libraries , 2008, J. Chem. Inf. Model..

[50]  Uko Maran,et al.  Combined Approach Using Ligand Efficiency, Cross-Docking, and Antitarget Hits for Wild-Type and Drug-Resistant Y181C HIV-1 Reverse Transcriptase , 2011, J. Chem. Inf. Model..

[51]  Gerhard Klebe,et al.  Development of new hydrogen-bond descriptors and their application to comparative molecular field analyses. , 2002, Journal of medicinal chemistry.

[52]  M. Lawrence,et al.  Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase , 1993, Journal of virology.

[53]  R. Cramer,et al.  Recent advances in comparative molecular field analysis (CoMFA). , 1989, Progress in clinical and biological research.

[54]  Kuo-Chen Chou,et al.  Prediction of G-protein-coupled receptor classes. , 2005, Journal of proteome research.